RHINOBLOCK
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

RHINOBLOCK Trademark

Serial Number: 77977300

RHINOBLOCK is a trademark filed by HerbalScience Nutraceuticals, Inc. on December 21, 2007. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

HerbalScience Nutraceuticals, Inc. (20 trademarks)

1004 Collier Center Way, Suite 200
Naples, FL 34110

Entity Type: 03

HERBALSCIENCE, INC. (19 trademarks)

SUITE 200
NAPLES, FL 34110

Entity Type: 03

Trademark Details

Filing Date

December 21, 2007

Registration Date

Not Registered

Published for Opposition

September 8, 2009

Goods & Services

Nutritional supplements; herbal products, namely, medicated skin and lip balms; herbal products for medical use, namely, medicated ointments, medicated oils, medicinal drinks, medicated syrups containing herbal extracts, bacterial poisons for medical purposes, and tinctures all for use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; herbal products for medicinal purposes, namely, medicinal herbal extracts and medicated syrups containing herbal extracts; medicinal herb extracts; medicinal herbal extracts for medical purposes; plant extracts for medical or pharmaceutical purposes; yeast extracts for medical or pharmaceutical purposes; Medicinal botanical extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tinctures, suppositories and filled ampule for injection used to treat skin ailments, for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; herbal products, namely, herbal powders being nutritional supplements; herbal products, namely, herbal powders in nutritional supplement drink mixes for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; oral preparations containing herbs or herbal extracts used to maintain health and for a wide variety of physical conditions; vitamin and mineral preparations intended for use as dietary supplements; vitamins; food supplements; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for medically restricted diets; food supplements, namely, anti-oxidants; food for diabetics, infants and enteral feeding; botanical extracts for nutritional use, namely, for use as nutritional supplements; botanical extracts sold as an integral ingredient in nutraceuticals and pharmaceuticals for the treatment of, or relief of symptoms in, infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, and/or inflammatory disorders and diseases, cancer and related conditions; anti-cough drops; cough drops; cough expectorants; cough lozenges; couch syrups; cough treatment preparations; cold sore treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; pharmaceutical preparations for the treatment and prevention of herpes; vaccines for the treatment and prevention of herpes; biological preparations for the treatment and prevention of herpes; pharmaceutical preparations for the treatment of herpes simplex infection; pharmaceutical capsules for the treatment of herpes simplex infection; homeopathic preparations for the treatment of herpes and cold sores; pharmaceutical preparations for the treatment of herpes viruses; medicated topical clear fluoride gel for the treatment of herpes virus during the physical manifestation of the virus; pharmaceutical preparations for the treatment of herpes simplex virus type I or type II or herpes zoster virus, not in intravenous form; plant based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral or antimicrobial properties, or both, for use in the treatment of herpetic keratitis, conjunctivitis, HIV retinopathy, viral influenza "flu", herpes simplex virus 1, herpes simplex virus 2, varicella zoster virus "herpes zoster" "shingles", cytomegalovirus, viral parainfluenza, adenovirus, viral encephalitis, viral meningitis, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, cold sores, human immune deficiency virus "HIV", roseola infantum, human herpes IV; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes; pharmaceutical preparations for treating immune diseases induced by virus, namely, herpes zoster and AIDS

Herbal extracts sold as an integral ingredient in cosmetics; pre-moistened non-medicated personal hygiene wipes, namely, herpes relief wipes

Botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals; chemical extracts and active principals extracted from medicinal plants for use in the manufacture of pharmaceuticals; and botanical extracts in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 6, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 5, 2010 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 1, 2009 NOAM
PUBLISHED FOR OPPOSITION
Sep 8, 2009 PUBO
NOTICE OF PUBLICATION
Aug 19, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 3, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2009 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jul 28, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2009 CRFA
PAPER RECEIVED
Jul 27, 2009 MAIL
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 20, 2009 GPRN
PRIORITY ACTION E-MAILED
Jul 20, 2009 GPRA
PRIORITY ACTION WRITTEN
Jul 20, 2009 CPRA
AMENDMENT FROM APPLICANT ENTERED
Jun 25, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2009 CRFA
PAPER RECEIVED
Jun 25, 2009 MAIL
EXAMINER'S AMENDMENT ENTERED
Jun 12, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 11, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 11, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 11, 2009 CNEA
NOTICE OF PSEUDO MARK MAILED
Jun 2, 2009 MPMK
DIVISIONAL PROCESSING COMPLETE
Jun 1, 2009 DPCC
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2009 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 18, 2009 ERFR
EX PARTE APPEAL-INSTITUTED
May 18, 2009 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 18, 2009 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 18, 2009 EXAF
DIVISIONAL REQUEST RECEIVED
Apr 21, 2009 DRRR
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Apr 21, 2009 UNTD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 13, 2009 AITU
PAPER RECEIVED
Apr 9, 2009 MAIL
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 1, 2009 ASGN
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 17, 2008 GNFN
FINAL REFUSAL E-MAILED
Nov 17, 2008 GNFR
FINAL REFUSAL WRITTEN
Nov 17, 2008 CNFR
AMENDMENT FROM APPLICANT ENTERED
Oct 27, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2008 CRFA
ASSIGNED TO LIE
Oct 22, 2008 ALIE
PAPER RECEIVED
Oct 7, 2008 MAIL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2008 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2008 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2008 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2008 DOCK
NOTICE OF PSEUDO MARK MAILED
Dec 29, 2007 MPMK
NEW APPLICATION ENTERED
Dec 28, 2007 NWAP